GlassScriptPhysician profile
Kristy Amore
NPI 1295025443
$2,277.45
in general payments reported to CMS, 2019-2025
25 companies · $95.98 in 2025
The $95.98 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $996 · 2023: $591 · 2024: $420 · 2025: $95.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $317.89 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $216.51 | 2021-2024 | |
| Hologic Sales and Service, LLC | $188.71 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Coopersurgical, INC. | $182.74 | 2022-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Organon LLC | $178.12 | 2021-2024 | Nexplanon, Nuvaring |
| Agile Therapeutics, INC. | $160.26 | 2021-2024 | Twirla |
| Amgen INC. | $138.90 | 2022-2024 | Evenity, Prolia |
| Astellas Pharma US INC | $118.35 | 2022-2024 | Veozah |
| Exeltis, USA INC. | $114.49 | 2021-2024 | Slynd |
| Aspira Women'S Health INC | $99.39 | 2022-2024 | Ova1 |
| Scynexis, INC. | $69.91 | 2022 | |
| Shield Therapeutics INC | $56.98 | 2022-2023 | Accrufer |
| Sumitomo Pharma America, INC. | $54.81 | 2024 | Myfembree |
| Boston Scientific Corporation | $54.28 | 2023-2025 | Bulkamid, Capio Rp |
| Pharmacosmos Therapeutics INC. | $43.25 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $39.97 | 2021 | |
| Ibsa Pharma INC. | $37.67 | 2023 | Tirosint, Licart |
| Medline Industries LP | $37.34 | 2024 | |
| Mission Pharmacal Company | $36.57 | 2023 | Citranatal |
| Bayer Healthcare Pharmaceuticals INC. | $26.82 | 2022 | |
| Avion Pharmaceuticals | $24.94 | 2022 | |
| Dysis Medical, INC. | $23.46 | 2022 | |
| Merck Sharp & Dohme LLC | $21.18 | 2022 | |
| Pfizer INC. | $19.48 | 2024 | |
| Roche Diabetes Care, INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Amore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.